RXR agonist S169 inhibits HBV/HDV entry in vitro by disrupting KIF4-dependent NTCP trafficking 2025/11/27 HBVHDVPXB-cells Gad, S. A. Abo Elwafa, D. A. Hussein, S. A. Fukano, K. Kato, T. Shoji, I. Chayama, K. Muramatsu, M. Isogawa, M. Wakita, T. Merk, D. Aly, H. H. Antiviral Res. 2025 Aug;240:106214. doi: 10.1016/j.antiviral.2025.106214. BACK Page top